Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 1 of 20

UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS
WACO DIVISION

JAQUISH BIOMEDICAL CORP., a

Delaware Corporation,
Civil Action No. 6:21-cv-52
Plaintiff,
COMPLAINT FOR PATENT
v. INFRINGEMENT
GYP TECHNOLOGY (HONGKONG)
CO. LTD. d/b/a TIKATON, a Chinese DEMAND FOR JURY TRIAL
company,
Defendant.
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 2 of 20

Plaintiff Jaquish Biomedical Corporation (“Jaquish Biomedical”), for its complaint

against Defendant GYP Technology (HongKong) Co. Ltd. (d/b/a “Tikaton”), hereby alleges as

follows:

NATURE OF THE ACTION

1. This is an action for patent infringement arising under the laws of the United

States, 35 U.S.C. § 101 et seq.

2. Jaquish Biomedical is the owner of all right, title, and interest in United States

Design Patents Nos. D902,330, D898,133, D895,739, D902,329, and D895,032 (collectively, the

“Patents-in-Suit,” attached hereto as Ex. A).

3. Tikaton has used and continues to use the claimed designs of the Patents-in-Suit

in its Tikaton Resistance Bars (the “Accused Products”), which Tikaton has made, used, offered

for sale, and sold in, and/or imported into, the United States.

4. Jaquish Biomedical seeks, among other things, permanent injunctive relief to stop

Tikaton from infringing the Patents-in-Suit; damages and/or disgorgement of Tikaton’s profits

from its infringing activities; pre-judgment and post-judgment interest; costs and attorneys’ fees;

and any and all other relief the Court deems just and proper.

THE PARTIES

5. Jaquish Biomedical is a Delaware Corporation with its principal place of business

at 14096 Sierra Woodlands Court, Nevada City, CA 95959.

6. On information and belief, Tikaton is a company from the People’s Republic of

China with its principal place of business at Xixiang Street, Bao’an District, Shenzhen, China 5,

A Block, Central Avenue Building, Shenzhen, Guangdong, 518101 China. The official Tikaton

website also identifies the following mailing address: RM 1902 Easey Comm Bldg 253-261

2
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 3 of 20

Hennessy Rd. Wanchai HK, HongKang, HongKong 999077 China. Upon information and

belief, Tikaton may be served with process, under the Hague Convention, at either address.

JURISDICTION AND VENUE

7. This is a civil action that arises under the Patent Laws of the United States, 35

U.S.C. § 1 et seq., including, but not limited to, 35 U.S.C. §§ 271 and 281. The Court has subject

matter jurisdiction pursuant to 28 U.S.C. §§ 1331 and 1338.

8. The Court has personal jurisdiction over Tikaton because, on information and

belief, (1) Tikaton has done and continues to do business in Texas and the Western District of

Texas, and (2) Tikaton has committed and continues to commit acts of patent infringement in the

State of Texas and in the Western District of Texas, including making, using, offering to sell,

and/or selling the Accused Products in the State of Texas and the Western District of Texas,

inducing others to commit acts of patent infringement in the State of Texas and the Western

District of Texas, and/or committing at least a portion of any other infringement alleged herein,

and (3) Tikaton has solicited business in the State of Texas and the Western District of Texas,

transacted business within the State of Texas and the Western District of Texas, and/or attempted

to derive financial remuneration from residents of the State of Texas and the residents of this

District, including benefits directly related to infringement of the Patents-in-Suit. Exercising

personal jurisdiction over Tikaton in this lawsuit comports with due process and traditional

notions of fair play and substantial justice.

9. Venue is proper in this Court pursuant to 28 U.S.C. § 1391(c)(3) because Tikaton

is not resident in the United States and thus may be sued in any judicial district in the United

States, including this District. Venue is also proper under 28 U.S.C. § 1391(b)(2) because

Tikaton sells and offers to sell products and services throughout the United States, including in

3
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 4 of 20

this District, and introduces products and services into the stream of commerce knowing that the

products and services would be sold in this District and elsewhere in the United States.

FACTUAL ALLEGATIONS

10. Jaquish Biomedical is well known around the world for its X3 system (the “X3”).

Through Jaquish Biomedical’s significant investment in research, design, development, and

marketing, the X3 has come to possess a distinctive design, instantly recognizable by its unique

features. These design features are essential to the X3 identity and are recognized in the

marketplace as a designator of the X3 brand.

11. Jaquish Biomedical has made significant investments, both in time and resources,

in developing the X3 and securing the intellectual property rights that protect it, including the

Patents-in-Suit.

Jaquish Biomedical’s Design Patents

12. On Nov. 17, 2020, the United States Patent & Trademark Office (“USPTO”)

issued U.S. Design Patent No. D902,330 titled “Exercise Apparatus” (“the ’330 patent”). A true

and correct copy of the ’330 patent is attached hereto as Exhibit A-1.

13. On Oct. 6, 2020, the USPTO issued U.S. Design Patent No. D898,133, titled

“Exercise Apparatus” (“the ’133 patent”). A true and correct copy of the ’133 patent is attached

hereto as Exhibit A-2.

14. On Sept. 8, 2020, the USPTO issued U.S. Design Patent No. D895,739, titled

“Exercise Apparatus” (“the ’739 patent”). A true and correct copy of the ’739 patent is attached

hereto as Exhibit A-3.

15. On Nov. 17, 2020, the USPTO issued U.S. Design Patent No. D902,329, titled

“Exercise Apparatus” (“the ’329 patent”). A true and correct copy of the ’329 patent is attached

4
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 5 of 20

hereto as Exhibit A-4.

16. On Sept. 1, 2020, the USPTO issued U.S. Design Patent No. D895,032, titled

“Exercise Apparatus” (“the ’032 patent”). A true and correct copy of the ’032 patent is attached

hereto as Exhibit A-5.

Tikaton’s Infringing Activities

17. As shown below, the Accused Products mimic several design features protected

by Jaquish Biomedical’s intellectual property, including its valuable patent rights.

18. Rather than create its own distinctive product design, Tikaton chose to embark on

a campaign to systematically copy the X3 in order to improperly exploit the goodwill Jaquish

Biomedical has spent years building in the marketplace. Even a cursory comparison of the X3 to

the design of an exemplary Accused Product reveals the extent of this misappropriation of

Jaquish Biomedical’s intellectual property.

X3 Bar

Tikaton Bar

19. Tikaton offers for sale and sells the Accused Products through its Amazon store

(https://www.amazon.com/s?k=Tikaton&ref=bl_dp_s_web_0), and a screenshot depicting an

exemplary Accused Product is shown below.

5
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 6 of 20

20. Upon information and belief, Tikaton has made, used, offered for sale, sold,

and/or imported the Accused Products into or in the United States, and continues to make, use,

offer for sale, sell, and/or import the Accused Products into or in the United States.

Tikaton’s Infringement Has Caused Actual Consumer Confusion

21. Tikaton’s blatant infringement of the X3 Bar and the patent rights claiming that

design have caused actual confusion among the relevant consuming public. Reviews from

Tikaton customers demonstrate the extent of Tikaton’s willful infringement and damage to

Jaquish Biomedical’s reputation in the marketplace.

22. Indeed, more than 30 customer reviews for the Accused Products on the Tikaton

Amazon store alone reference the X3 Bar. As just one example, on April 21, 2020, a Tikaton

customer identified as “Ryan” published the following 1-star review for the Accused Products on

the Tikaton Amazon store: “Cheap rip off of the X3 Bar. This is an illegal product trying to

copy the X3. The hooks do not move well and are not together. This product will be taken down

soon.”

23. Likewise, on February 29, 2020, a Tikaton customer identified as “Seth M.”

published the following 1-star review for the Accused Products on the Tikaton Amazon store:

“This is a knock-off X3 system.”

6
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 7 of 20

24. As another example, on April 24, 2020, another Tikaton customer published the

following 1-star review for the Accused Products on the Tikaton Amazon store: “Do not buy this

cheap x3 knock off sold by a shady company in China.”

25. Similarly, on June 11, 2020, a Tikaton customer named “Phillip M. Schlueter”

published the following 1-star review for the Accused Products on the Tikaton Amazon store:

“Knock off for the X3.”

26. As yet another example, on June 15, 2020, a Tikaton customer identified as

“Salvador” published the following 1-star review for the Accused Products on the Tikaton

Amazon store “Cheap copy of the X3 bar.”

27. Several X3 customers have also reported Tikaton’s infringement to Jaquish

Biomedical directly. As one example, a X3 customer identified as “Amir K” emailed a link to

the Tikaton Amazon store to Jaquish Biomedical’s customer support team and stated: “Just

wanted to let you know about a fake knock-off product, hopefully you can get it removed from

Amazon.”

28. As another example, a X3 customer identified as “Hal W” emailed Jaquish

Biomedical’s customer support team stating: “I'm enjoying my X3 Bar, but you have a ripoff

called - Tikaton Resistance Bar Portable Home Gym on Amazon and I think, also on ebay. It

looks like they copied your bar exactly!”

29. Tikaton’s ongoing and unauthorized acts of patent infringement are not only

causing lost sales, they are damaging the reputation and the goodwill associated with the X3

brand that Jaquish Biomedical has spent years building.

Tikaton Refused to Cease Its Blatant Infringement

30. On October 16, 2020, counsel for Jaquish Biomedical sent Tikaton a letter

7
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 8 of 20

demonstrating that the Accused Products infringe the Patents-in-Suit, providing proof of actual

customer confusion caused by the infringement, and requesting that Tikaton immediately cease

and desist from any further acts of infringement.

31. Tikaton’s counsel responded on Novermber 13, 2020, contending that “GYP

Technology Co. does not think the TIKATON Resistance Bar infringe any of the Jaquish

Biomedical’s design patents” based on an improper analysis of each element of the design

separately, focusing on alleged minor differences in specific design details, rather than the

overall appearance of the Accused Products as required under the law. This letter did not dispute

the widespread confusion in the marketplace over whether the Accused Tikaton products were

made by Jaquish Biomedical and did not question that many customers have purchased the

Accused Tikaton products mistaking them for the X3.

32. Counsel for Jaquish Biomedical sent another letter to Tikaton’s counsel on

December 3, 2020 identifying the fatal deficiencies in Tikaton’s infringement analysis and once

again demanding that Tikaton immediately cease its infringing activities.

33. Tikaton never responded to Jaquish Biomedical’s December 3 letter and

continued its importation and sale of the Accused Products.

FIRST CLAIM FOR RELIEF

(Infringement of the ’330 Patent – 35 U.S.C. § 271)

34. Paragraphs 1 through 33 are incorporated by reference as if fully stated herein.

35. Jaquish Biomedical owns all rights, title, and interest in the ’330 patent.

36. At least as early as Oct. 16, 2020, Tikaton had actual notice of its infringement of

the claimed subject matter in United States Design Patent Application No. 29/734,092 and of the

fact that a patent based on this application was expected to issue imminently. This application

issued as the ’330 patent on November 17, 2020, and Tikaton knew and/or should have know of

8
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 9 of 20

its infringement of the issued ’330 patent on this date.

37. Tikaton, without authorization from Jaquish Biomedical, has made, used, offered

for sale, sold, and/or imported into or in the United States, and continues to make, use, offer for

sale, sell, and/or import into or in the United States, the Accused Products having designs

substantially similar to the ’330 patent.

38. Table 1 compares an exemplary figure from the ’330 patent with an advertisement

of an exemplary Accused Product from a corresponding view.

TABLE 1
The ’330 Patent Exemplary Accused Product

39. By the foregoing acts, Tikaton has infringed, literally and/or under the doctrine of

equivalents, and continues to infringe, the ’330 patent in violation of 35 U.S.C. § 271.

40. Upon information and belief, Tikaton’s infringement of the ’330 patent is, has

9
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 10 of 20

been, and continues to be, undertaken knowingly, willfully, deliberately, maliciously, and in bad

faith, entitling Jaquish Biomedical to enhanced damages under 35 U.S.C. § 284 and to attorneys’

fees and expenses incurred in prosecuting this action under 35 U.S.C. § 285.

41. Upon information and belief, Tikaton has gained profits by virtue of its

infringement of the ’330 patent.

42. Upon information and belief, Tikaton has obtained further investment by virtue of

its infringement of the ’330 patent.

43. As a direct and proximate result of Tikaton’s infringement of the ’330 patent,

Jaquish Biomedical has been and continues to be damaged in an amount yet to be determined.

44. Jaquish Biomedical will suffer and is suffering irreparable harm from Tikaton’s

infringement of the ’330 patent. Jaquish Biomedical has no adequate remedy at law and is

entitled to an injunction against Tikaton’s infringement of the ’330 patent. Unless enjoined by

this Court, Tikaton will continue its infringing conduct, thereby causing Jaquish Biomedical to

further sustain irreparable damage, loss, and injury, for which it has no adequate remedy at law.

SECOND CLAIM FOR RELIEF

(Infringement of the ’133 Patent – 35 U.S.C. § 271)

45. Paragraphs 1 through 44 are incorporated by reference as if fully stated herein.

46. Jaquish Biomedical owns all rights, title, and interest in the ’133 patent.

47. Tikaton had actual notice of its infringement of the ’133 patent at least since Oct.

16, 2020.

48. Tikaton, without authorization from Jaquish Biomedical, has made, used, offered

for sale, sold, and/or imported into or in the United States, and continues to make, use, offer for

sale, sell, and/or import into or in the United States, the Accused Products having designs

substantially similar to the ’133 patent.

10
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 11 of 20

49. Table 2 compares an exemplary figure from the ’133 patent with an advertisement

of an exemplary Accused Product from a corresponding view.

TABLE 2
The ’133 Patent Exemplary Accused Product

50. By the foregoing acts, Tikaton has infringed, literally and/or under the doctrine of

equivalents, and continues to infringe, the ’133 patent in violation of 35 U.S.C. § 271.

51. Upon information and belief, Tikaton’s infringement of the ’133 patent is, has

been, and continues to be, undertaken knowingly, willfully, deliberately, maliciously, and in bad

faith, entitling Jaquish Biomedical to enhanced damages under 35 U.S.C. § 284 and to attorneys’

fees and expenses incurred in prosecuting this action under 35 U.S.C. § 285.

52. Upon information and belief, Tikaton has gained profits by virtue of its

infringement of the ’133 patent.

11
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 12 of 20

53. Upon information and belief, Tikaton has obtained further investment by virtue of

its infringement of the ’133 patent.

54. As a direct and proximate result of Tikaton’s infringement of the ’133 patent,

Jaquish Biomedical has been and continues to be damaged in an amount yet to be determined.

55. Jaquish Biomedical will suffer and is suffering irreparable harm from Tikaton’s

infringement of the ’133 patent. Jaquish Biomedical has no adequate remedy at law and is

entitled to an injunction against Tikaton’s infringement of the ’133 patent. Unless enjoined by

this Court, Tikaton will continue its infringing conduct, thereby causing Jaquish Biomedical to

further sustain irreparable damage, loss, and injury, for which it has no adequate remedy at law.

THIRD CLAIM FOR RELIEF

(Infringement of the ’739 Patent – 35 U.S.C. § 271)

56. Paragraphs 1 through 55 are incorporated by reference as if fully stated herein.

57. Jaquish Biomedical owns all rights, title, and interest in the ’739 patent.

58. Tikaton had actual notice of its infringement of the ’739 patent since at least Oct.

16, 2020.

59. Tikaton, without authorization from Jaquish Biomedical, has made, used, offered

for sale, sold, and/or imported into or in the United States, and continues to make, use, offer for

sale, sell, and/or import into or in the United States, the Accused Products having designs

substantially similar to the ’739 patent.

60. Table 3 compares an exemplary figure from the ’739 patent with an advertisement

of an exemplary Accused Product from a corresponding view.

12
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 13 of 20

TABLE 3
The ’739 Patent Exemplary Accused Product

61. By the foregoing acts, Tikaton has infringed, literally and/or under the doctrine of

equivalents, and continues to infringe, the ’739 patent in violation of 35 U.S.C. § 271.

62. Upon information and belief, Tikaton’s infringement of the ’739 patent is, has

been, and continues to be, undertaken knowingly, willfully, deliberately, maliciously, and in bad

faith, entitling Jaquish Biomedical to enhanced damages under 35 U.S.C. § 284 and to attorneys’

fees and expenses incurred in prosecuting this action under 35 U.S.C. § 285.

63. Upon information and belief, Tikaton has gained profits by virtue of its

infringement of the ’739 patent.

64. Upon information and belief, Tikaton has obtained further investment by virtue of

its infringement of the ’739 patent.

13
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 14 of 20

65. As a direct and proximate result of Tikaton’s infringement of the ’739 patent,

Jaquish Biomedical has been and continues to be damaged in an amount yet to be determined.

66. Jaquish Biomedical will suffer and is suffering irreparable harm from Tikaton’s

infringement of the ’739 patent. Jaquish Biomedical has no adequate remedy at law and is

entitled to an injunction against Tikaton’s infringement of the ’739 patent. Unless enjoined by

this Court, Tikaton will continue its infringing conduct, thereby causing Jaquish Biomedical to

further sustain irreparable damage, loss, and injury, for which it has no adequate remedy at law.

FOURTH CLAIM FOR RELIEF

(Infringement of the ’329 Patent – 35 U.S.C. § 271)

67. Paragraphs 1 through 66 are incorporated by reference as if fully stated herein.

68. Jaquish Biomedical owns all rights, title, and interest in the ’329 patent.

69. The ’329 patent issued on November 17, 2020, and Tikaton knew and/or should

have known of its infringement of the issued ’329 patent on this date.

70. Tikaton, without authorization from Jaquish Biomedical, has made, used, offered

for sale, sold, and/or imported into or in the United States, and continues to make, use, offer for

sale, sell, and/or import into or in the United States, the Accused Products having designs

substantially similar to the ’329 patent.

71. Table 1 compares an exemplary figure from the ’329 patent with an advertisement

of an exemplary Accused Product from a corresponding view.

14
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 15 of 20

TABLE 4
The ’329 Patent Exemplary Accused Product

72. By the foregoing acts, Tikaton has infringed, literally and/or under the doctrine of

equivalents, and continues to infringe, the ’329 patent in violation of 35 U.S.C. § 271.

73. Upon information and belief, Tikaton’s infringement of the ’329 patent is, has

been, and continues to be, undertaken knowingly, willfully, deliberately, maliciously, and in bad

faith, entitling Jaquish Biomedical to enhanced damages under 35 U.S.C. § 284 and to attorneys’

fees and expenses incurred in prosecuting this action under 35 U.S.C. § 285.

74. Upon information and belief, Tikaton has gained profits by virtue of its

infringement of the ’329 patent.

75. Upon information and belief, Tikaton has obtained further investment by virtue of

its infringement of the ’329 patent.

15
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 16 of 20

76. As a direct and proximate result of Tikaton’s infringement of the ’329 patent,

Jaquish Biomedical has been and continues to be damaged in an amount yet to be determined.

77. Jaquish Biomedical will suffer and is suffering irreparable harm from Tikaton’s

infringement of the ’329 patent. Jaquish Biomedical has no adequate remedy at law and is

entitled to an injunction against Tikaton’s infringement of the ’329 patent. Unless enjoined by

this Court, Tikaton will continue its infringing conduct, thereby causing Jaquish Biomedical to

further sustain irreparable damage, loss, and injury, for which it has no adequate remedy at law.

FIFTH CLAIM FOR RELIEF

(Infringement of the ’032 Patent – 35 U.S.C. § 271)

78. Paragraphs 1 through 77 are incorporated by reference as if fully stated herein.

79. Jaquish Biomedical owns all rights, title, and interest in the ’032 patent.

80. Tikaton knew and/or should have known of its infringement of the ’032 patent by

at least least Oct. 16, 2020.

81. Tikaton, without authorization from Jaquish Biomedical, has made, used, offered

for sale, sold, and/or imported into or in the United States, and continues to make, use, offer for

sale, sell, and/or import into or in the United States, the Accused Products having designs

substantially similar to the ’032 patent.

82. Table 1 compares an exemplary figure from the ’032 patent with an advertisement

of an exemplary Accused Product from a corresponding view.

16
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 17 of 20

TABLE 5
The ’032 Patent Exemplary Accused Product

83. By the foregoing acts, Tikaton has infringed, literally and/or under the doctrine of

equivalents, and continues to infringe, the ’032 patent in violation of 35 U.S.C. § 271.

84. Upon information and belief, Tikaton’s infringement of the ’032 patent is, has

been, and continues to be, undertaken knowingly, willfully, deliberately, maliciously, and in bad

faith, entitling Jaquish Biomedical to enhanced damages under 35 U.S.C. § 284 and to attorneys’

fees and expenses incurred in prosecuting this action under 35 U.S.C. § 285.

85. Upon information and belief, Tikaton has gained profits by virtue of its

infringement of the ’032 patent.

86. Upon information and belief, Tikaton has obtained further investment by virtue of

17
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 18 of 20

its infringement of the ’032 patent.

87. As a direct and proximate result of Tikaton’s infringement of the ’032 patent,

Jaquish Biomedical has been and continues to be damaged in an amount yet to be determined.

88. Jaquish Biomedical will suffer and is suffering irreparable harm from Tikaton’s

infringement of the ’032 patent. Jaquish Biomedical has no adequate remedy at law and is

entitled to an injunction against Tikaton’s infringement of the ’032 patent. Unless enjoined by

this Court, Tikaton will continue its infringing conduct, thereby causing Jaquish Biomedical to

further sustain irreparable damage, loss, and injury, for which it has no adequate remedy at law.

REQUEST FOR RELIEF

WHEREFORE, Jaquish Biomedical prays for judgment against Tikaton as follows:

A. A judgment and order adjudicating and declaring that Tikaton has infringed each

of the Patents-in-Suit;

C. A judgment and order permanently enjoining Tikaton, its officers, agents,

servants, employees, attorneys and all persons in active concert or participation with Tikaton,

from further infringement of the Patents-in-Suit;

D. A judgment and order that Tikaton must account and pay actual damages,

including a disgorgement of Tikaton’s profits and/or any lost profits or other harm to Jaquish

Biomedical (but no less than a reasonable royalty), to Jaquish Biomedical for Tikaton’s

infringement of the Patents-in-Suit;

E. A judgment and order awarding Jaquish Biomedical the total profits realized by

Tikaton from its infringement of the Patents-in-Suit pursuant to 35 U.S.C. § 289;

F. A judgment and order declaring that Tikaton has willfully infringed the Patents-

in-Suit;

18
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 19 of 20

G. A judgment and order awarding Jaquish Biomedical damages adequate to

compensate for Tikaton’s infringement together with enhanced damages up to three times any

amount ordered pursuant to 35 U.S.C. § 284;

H. A determination that this is an exceptional case under 35 U.S.C. § 285;

I. A judgment and order awarding Jaquish Biomedical its reasonable attorneys’ fees;

J. A judgment and order awarding Jaquish Biomedical its costs, expenses, and

interest, including pre-judgment and post-judgment interest, as provided for by 35 U.S.C. § 284;

L. A judgement and order awarding punitive or exemplary damages where

appropriate;

M. A judgment and order awarding Jaquish Biomedical both pre-judgment and post-

judgment interest on each and every monetary award; and

N. Granting Jaquish Biomedical such other and further relief as the Court deems just

and appropriate, or that Jaquish Biomedical may be entitled to as a matter of law or equity.

DEMAND FOR JURY TRIAL

In accordance with Federal Rule of Civil Procedure 38, Jaquish Biomedical respectfully

demands a jury trial of all issues triable to a jury in this action.

19
 Case 6:21-cv-00052 Document 1 Filed 01/19/21 Page 20 of 20

Dated: January 19, 2021 Respectfully submitted,

MORGAN, LEWIS & BOCKIUS LLP

By /s/ Elizabeth M. Chiaviello

Elizabeth M. Chiaviello
State Bar No. 24088913
elizabeth.chiaviello@morganlewis.com
MORGAN, LEWIS & BOCKIUS LLP
1717 Main Street, Suite 3200
Dallas, Texas 75201-7347
T: 1.214.466.4000
F: 1.214.466.4001
Michael J. Lyons
(pro hac vice pending)
michael.lyons@morganlewis.com
Ehsun Forghany
(pro hac vice pending)
ehsun.forghany@morganlewis.com
MORGAN, LEWIS & BOCKIUS LLP
1400 Page Mill Road
Palo Alto, CA 94304
T: 1.650.843.4000
F: 1.650.843.4001
Attorneys for Plaintiff Jaquish
Biomedical

20
Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 1 of 56

EXHIBIT A-1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 2 of 56

USOOD902330S

( 12 ) Jaquish
Unitedet alStates
.
Design Patent ((4510)) Date
PatentofNoPatent
.: : US D902,330 S
** *Nov. 17, 2020
( 54 ) EXERCISE APPARATUS 4,200,281 A 4/1980 Wang
4,257,592 A 3/1981 Jones
( 71 ) Applicant: Jaquish Biomedical Corporation , 4,441,707 A 4/1984 Bosch
5,178,596 A 1/1993 McIntire
Nevada City, CA (US ) 5,197,934 A 3/1993 Wirtz
D342,771 S 12/1993 Tandberg
( 72 ) Inventors : John Paul Jaquish , Nevada City, CA D353,419 S 12/1994 Sprague
(US ) ; Paul Edward Jaquish , Nevada 5,514,058 A 5/1996 Buoni
City, CA ( US ) 5,540,642 A 7/1996 Sprague
5,653,665 A 8/1997 Neeley
5,688,213 A 11/1997 Recker
( 73 ) Assignee : Jaquish Biomedical Corporation , (Continued )
Nevada City, CA (US )
This patent is subject to a terminal dis FOREIGN PATENT DOCUMENTS
( * ) Notice :
claimer. EP 2764896 A1 8/2014
KR 10200000 5/2000
( ** ) Term : 15 Years
Primary Examiner — George D. Kirschbaum
( 21 ) Appl. No .: 29 /734,092 (74 ) Attorney, Agent, or Firm — Morgan , Lewis &
Bockius LLP
(22 ) Filed : May 8, 2020
Related U.S. Application Data ( 57 ) CLAIM
( 63 ) Continuation of application No. 35 / 001,051 , filed on The ornamental design for an exercise apparatus, as shown
and described .
Jul. 17 , 2015 (U.S. filing date under 35 U.S.C. 384 ) ,
and having an international filing date of Jul . 17 , DESCRIPTION
2015 , which is a continuation of application No.
29/ 515,595 , filed on Jan. 23 , 2015 , now Pat . No. Des .
778,374 . FIG . 1 is a first perspective view of an exercise apparatus
( 51 ) LOC ( 12) Cl . 21-02 showing our new design ;
(52) U.S. CI. FIG . 2 is a second perspective view thereof;
USPC D21 /673 FIG . 3 is a front view of the design of FIG . 2 ;
FIG . 4 is a rear view of the design of FIG . 2 ;
( 58 ) Field of Classification Search FIG . 5 is a side view of the design of FIG . 2 , wherein the
USPC D21 / 662 , 673 , 679 opposite side of the exercise apparatus is a mirror image of
CPC A63B 23/0355 ; A63B 23/03525 ; A63B the side view ;
21/0552 , A63B 21/02 , A63B 21/0004 FIG . 6 is a top view of the design of FIG . 2 ;
See application file for complete search history . FIG . 7 is an enlarged view of FIG . 1 ; and,
( 56 ) References Cited FIG . 8 is a cross - sectional view taken along the lines 8-8 of
FIG . 7 .
U.S. PATENT DOCUMENTS The broken lines depict unclaimed environmental subject
matter.
1,019,861 A 3/1912 Titus
3,193,288 A 7/1965 Vell 1 Claim , 8 Drawing Sheets
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 3 of 56

US D902,330 S
Page 2

( 56 ) References Cited D657,008 S 4/2012

11/2012
Markovic
Guarrasi
D670,345 S
U.S. PATENT DOCUMENTS D682,374 S 5/2013 Wilkinson
8,870,722 B2 10/2014 Kassel
5,746,687 A * 5/1998 Vial A63B 21/0552 D723,637 S 3/2015 Mercado
482/125 D724,163 S 3/2015 Kelley
5,776,041 A 7/1998 Fisher 9,254,405 B1 * 2/2016 Marji A63B 21/02
5,885,196 A 3/1999 Gvoich A63B 21/0004 D764,607 S 8/2016 Beckford
482/122 2002/0137609 Al 9/2002 Rosati
6,203,476 B1 3/2001 Wang et al . 2005/0239617 A1 10/2005 Tenaglia
6,280,366 B1 8/2001 Hsieh 2007/0207903 A1 9/2007 Csabai
D474,818 S 5/2003 Yu 2007/0207905 Al 9/2007 Winston
D482,748 S 11/2003 Flynt 2010/0152002 A1 * 6/2010 Knight A63B 21/0552
7,052,449 B2 5/2006 Chen 482/93
D526,367 S 8/2006 Loccarini 2010/0173760 A1 * 7/2010 Hall A63B 23/03525
7,175,574 B2 2/2007 Carmel et al . 482/129
7,387,599 B1 6/2008 Hsu 2014/0038793 A1 * 2/2014 Hetzel A63B 23/0355
D590,457 S 4/2009 Mishan 482/122
7,578,775 B2 8/2009 Terry 2014/0228180 A1 8/2014 Walker
7,601,101 B2 10/2009 Jackson 2015/0367159 Al 12/2015 Harris
D604,374 S 11/2009 Bizzell
7,922,624 B1 4/2011 Fairhurst * cited by examiner
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 4 of 56

U.S. Patent Nov. 17 , 2020 Sheet 1 of 8 US D902,330 S

1
1
1

1
1

Figure 7

Figure 1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 5 of 56

U.S. Patent Nov. 17 , 2020 Sheet 2 of 8 US D902,330 S

1
1

Figure 2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 6 of 56

U.S. Patent Nov. 17 , 2020 Sheet 3 of 8 US D902,330 S

07752

1
1 1 1
1

11

1 1
1

Figure 3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 7 of 56

U.S. Patent Nov. 17 , 2020 Sheet 4 of 8 US D902,330 S

1
1
1

1
1
1
1

1 1

Figure 4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 8 of 56

U.S. Patent Nov. 17 , 2020 Sheet 5 of 8 US D902,330 S

1
1

1
1

1
1

Figure 5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 9 of 56

U.S. Patent Nov. 17 , 2020 Sheet 6 of 8 US D902,330 S

A.

Figure 6
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 10 of 56

U.S. Patent Nov. 17 , 2020 Sheet 7 of 8 US D902,330 S

8
red

Figure 7
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 11 of 56

U.S. Patent Nov. 17 , 2020 Sheet 8 of 8 US D902,330 S

HABARI
=

Figure 8
Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 12 of 56

EXHIBT A-2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 13 of 56

USOOD898133S

( 12 ) Jaquish
Unitedet alStates
.
Design Patent ((4510)) Date
PatentofNoPatent
.: : US D898,133 S
* Oct . 6 , 2020
( 54 ) EXERCISE APPARATUS 4,200,281 A 4/1980 Wang
4,257,592 A 3/1981 Jones
( 71 ) Applicant: Jaquish Biomedical Corporation , 4,441,707 A 4/1984 Bosch
5,178,596 A 1/1993 McIntire
Nevada City, CA (US ) 5,197,934 A 3/1993 Wirtz
D342,771 S 12/1993 Tandberg
( 72 ) Inventors : John Paul Jaquish , Nevada City, CA D353,419 S 12/1994 Sprague
(US ) ; Paul Edward Jaquish , Nevada 5,514,058 A 5/1996 Buoni
City, CA ( US ) 5,540,642 A 7/1996 Sprague
5,653,665 A 8/1997 Neeley
( 73 ) Assignee : Jaquish Biomedical Corporation , (Continued )
Nevada City, CA (US ) FOREIGN PATENT DOCUMENTS
( * ) Notice : This patent is subject to a terminal dis EP 2764896 A1 8/2014
claimer. KR 10200000 5/2000
( ** ) Term : 15 Years Primary Examiner George D. Kirschbaum
( 74 ) Attorney, Agent, or Firm Morgan , Lewis &
( 21 ) Appl . No .: 29 /734,091 Bockius LLP
( 22 ) Filed : May 8, 2020 ( 57 ) CLAIM
Related U.S. Application Data The ornamental design for an exercise apparatus, as shown
and described .
( 63 ) Continuation of application No. 35 / 001,051 , filed on DESCRIPTION
Jul. 17 , 2015 (U.S. filing date under 35 U.S.C. 384 ) ,
and having an international filing date of Jul . 17 ,
2015 , which is a continuation of application No. FIG . 1 is a first perspective view of an exercise apparatus
29/ 515,595 , filed on Jan. 23 , 2015 , now Pat . No. Des . showing our new design;
778,374 . FIG . 2 is a second perspective view thereof;
( 51 ) LOC ( 12) Cl . 21-02 FIG . 3 is a front view of the design of FIG . 2 ;
( 52) U.S. Cl. FIG . 4 is a rear view of the design of FIG . 2 ;
USPC D21 /673 FIG . 5 is a side view of the design of FIG . 2 , wherein the
(58) Field of Classification Search
opposite side of the exercise apparatus is a mirror image of
the side view ;
USPC D21 / 662 , 673 , 679 FIG . 6 is a top view of the design of FIG . 2 ;
CPC A63B 23/0355 ; A63B 23/03525 ; A63B FIG . 7 is a bottom view of the design of FIG . 2 ;
21/0552 ; A63B 21/02 , A63B 21/004 FIG . 8 is a first enlarged view of FIG . 1 ;
See application file for complete search history. FIG . 9 is a second enlarged view of FIG . 1 ; and,
( 56 ) References Cited FIG . 10 is a cross - sectional view taken along the lines 1-10
of FIG . 8 .
U.S. PATENT DOCUMENTS The broken lines depict unclaimed environmental subject
matter .
1,019,861 A 3/1912 Titus
3,193,288 A 7/1965 Vell 1 Claim , 9 Drawing Sheets
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 14 of 56

US D898,133 S
Page 2

( 56 ) References Cited 7,922,624

D657,008
B1
S
4/2011
4/2012
Fairhurst
Markovic
U.S. PATENT DOCUMENTS D670,345 S 11/2012 Guarrasi
D682,374 S 5/2013 Wilkinson
5,688,213 A 11/1997 Recker 8,870,722 B2 10/2014 Kassel
5,746,687 A * 5/1998 Vial A63B 21/0552 D723,637 S 3/2015 Mercado
482/125 D724,163 S 3/2015 Kelley
5,776,041 A 7/1998 Fisher 9,254,405 B1 * 2/2016 Marji A63B 21/02
5,885,196 A * 3/1999 Gvoich A63B 21/0004 D764,607 S 8/2016 Beckford
482/122 2002/0137609 Al 9/2002 Rosati
6,203,476 B1 3/2001 Wang et al. 2005/0239617 Al 10/2005 Tenaglia
6,280,366 B1 8/2001 Hsieh 2007/0207903 A1 9/2007 Csabai
D474,818 S 5/2003 Yu 2007/0207905 A1 9/2007 Winston
D482,748 S 11/2003 Flynt 2010/0152002 A1 * 6/2010 Knight A63B 21/0552
7,052,449 B2 5/2006 Chen 482/93
8/2006 Loccarini 2010/0173760 A1 * 7/2010 Hall A63B 23/03525
D526,367 S 482/129
7,175,574 B2 2/2007 Carmel et al . 2014/0038793 A1 * 2/2014 Hetzel A63B 23/0355
7,387,599 B1 6/2008 Hsu 482/122
D590,457 S 4/2009 Mishan 2014/0228180 A1 8/2014 Walker
7,578,775 B2 8/2009 Terry 2015/0367159 Al 12/2015 Harris
7,601,101 B2 10/2009 Jackson
D604,374 S 11/2009 Bizzell * cited by examiner
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 15 of 56

U.S. Patent Oct. 6 , 2020 Sheet 1 of 9 US D898,133 S

1 I
1
1
1

Figure 8
1

lu
Figure 9

Figure 1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 16 of 56

U.S. Patent Oct. 6 , 2020 Sheet 2 of 9 US D898,133 S

rue

1
1
1 1
1
1

1
1

Figure 2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 17 of 56

U.S. Patent Oct. 6 , 2020 Sheet 3 of 9 US D898,133 S

20 ; 152

f
1
1
1

U
1
1

-LRA A.

Figure 3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 18 of 56

U.S. Patent Oct. 6 , 2020 Sheet 4 of 9 US D898,133 S

1 }
1 I

L
L
1

1
1
1 1

}
$
I

Figure 4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 19 of 56

U.S. Patent Oct. 6 , 2020 Sheet 5 of 9 US D898,133 S

1
}
1

1
}

1
I

Figure 5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 20 of 56

U.S. Patent Oct. 6 , 2020 Sheet 6 of 9 US D898,133 S

ur
pH

Figure 6

home

ornet 1 mo

FH H
H FIFT

Figure 7
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 21 of 56

U.S. Patent Oct. 6 , 2020 Sheet 7 of 9 US D898,133 S

a .
1

10

10
ed

Figure 8
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 22 of 56

U.S. Patent Oct. 6.2020 Sheet 8 of 9 US D898.133 S

====
*
?

Figure 9
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 23 of 56

U.S. Patent Oct. 6 , 2020 Sheet 9 of 9 US D898,133 S

are =

Figure 10
Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 24 of 56

EXHIBIT A-3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 25 of 56

USOOD895739S

( 12 ) Jaquish
Unitedet alStates
.
Design Patent ((4510)) Date
PatentofNoPatent
.: : US D895,739 S
*Sep. 8, 2020
( 54 ) EXERCISE APPARATUS 4,200,281 A 4/1980 Wang
4,257,592 A 3/1981 Jones
( 71 ) Applicant: Jaquish Biomedical Corporation , 4,441,707 A 4/1984 Bosch
5,178,596 A 1/1993 McIntire
Nevada City, CA (US ) 5,197,934 A 3/1993 Wirtz
D342,771 S 12/1993 Tandberg
( 72 ) Inventors : John Paul Jaquish , Nevada City, CA D353,419 S 12/1994 Sprague
(US ) ; Paul Edward Jaquish , Nevada 5,514,058 A 5/1996 Buoni
City, CA ( US ) 5,540,642 A 7/1996 Sprague
5,653,665 A 8/1997 Neeley
5,688,213 A 11/1997 Recker
( 73 ) Assignee : Jaquish Biomedical Corporation , (Continued )
Nevada City, CA (US )
This patent is subject to a terminal dis FOREIGN PATENT DOCUMENTS
( * ) Notice :
claimer. EP 2764896 A1 8/2014
KR 10200000 5/2000
( ** ) Term : 15 Years
Primary Examiner — George D. Kirschbaum
( 21 ) Appl . No .: 29 /734,014 (74 ) Attorney, Agent, or Firm — Morgan , Lewis &
Bockius LLP
(22 ) Filed : May 8, 2020
Related U.S. Application Data ( 57 ) CLAIM
( 63 ) Continuation of application No. 35 / 001,051 , filed on The ornamental design for an exercise apparatus, as shown
and described .
Jul. 17 , 2015 (U.S. filing date under 35 U.S.C. 384 ) ,
and having an international filing date of Jul . 17 , DESCRIPTION
2015 , which is a continuation of application No.
29/ 515,595 , filed on Jan. 23 , 2015 , now Pat . No. Des .
778,374 . FIG . 1 is a first perspective view of an exercise apparatus
( 51 ) LOC ( 12) Cl . 21-02 showing our new design ;
(52) U.S. CI. FIG . 2 is a second perspective view thereof;
USPC D21 /673 FIG . 3 is a front view of the design of FIG . 2 ;
FIG . 4 is a rear view of the design of FIG . 2 ;
( 58 ) Field of Classification Search FIG . 5 is a side view of the design of FIG . 2 , wherein the
USPC D21 / 662 , 673 , 679 opposite side of the exercise apparatus is a mirror image of
CPC A63B 23/0355 ; A63B 23/03525 ; A63B the side view ;
21/0552 , A63B 21/02 , A63B 21/0004 FIG . 6 is a top view of the design of FIG . 2 ;
See application file for complete search history . FIG . 7 is a bottom view of the design of FIG . 2 ;
( 56 ) References Cited FIG . 8 is a first enlarged view of FIG . 1 ; and,
FIG . 9 is a second enlarged view of FIG . 1 .
U.S. PATENT DOCUMENTS The broken lines depict unclaimed environmental subject
matter.
1,019,861 A 3/1912 Titus
3,193,288 A 7/1965 Vell 1 Claim , 8 Drawing Sheets
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 26 of 56

US D895,739 S
Page 2

( 56 ) References Cited D657,008 S 4/2012

11/2012
Markovic
Guarrasi
D670,345 S
U.S. PATENT DOCUMENTS D682,374 S 5/2013 Wilkinson
8,870,722 B2 10/2014 Kassel
5,746,687 A * 5/1998 Vial A63B 21/0552 D723,637 S 3/2015 Mercado
482/125 D724,163 S 3/2015 Kelley
5,776,041 A 7/1998 Fisher 9,254,405 B1 * 2/2016 Marji A63B 21/02
5,885,196 A 3/1999 Gvoich A63B 21/0004 D764,607 S 8/2016 Beckford
482/122 2002/0137609 Al 9/2002 Rosati
6,203,476 B1 3/2001 Wang et al . 2005/0239617 A1 10/2005 Tenaglia
6,280,366 B1 8/2001 Hsieh 2007/0207903 A1 9/2007 Csabai
D474,818 S 5/2003 Yu 2007/0207905 Al 9/2007 Winston
D482,748 S 11/2003 Flynt 2010/0152002 A1 * 6/2010 Knight A63B 21/0552
7,052,449 B2 5/2006 Chen 482/93
D526,367 S 8/2006 Loccarini 2010/0173760 A1 * 7/2010 Hall A63B 23/03525
7,175,574 B2 2/2007 Carmel et al . 482/129
7,387,599 B1 6/2008 Hsu 2014/0038793 A1 * 2/2014 Hetzel A63B 23/0355
D590,457 S 4/2009 Mishan 482/122
7,578,775 B2 8/2009 Terry 2014/0228180 A1 8/2014 Walker
7,601,101 B2 10/2009 Jackson 2015/0367159 Al 12/2015 Harris
D604,374 S 11/2009 Bizzell
7,922,624 B1 4/2011 Fairhurst * cited by examiner
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 27 of 56

U.S. Patent Sep. 8, 2020 Sheet 1 of 8 US D895,739 S

Figure 8

Figure 9

Figure 1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 28 of 56

U.S. Patent Sep. 8, 2020 Sheet 2 of 8 US D895,739 S

????

Figure 2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 29 of 56

U.S. Patent Sep. 8, 2020 Sheet 3 of 8 US D895,739 S

CD ; KCE

I 1

1
1
1

Figure 3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 30 of 56

U.S. Patent Sep. 8, 2020 Sheet 4 of 8 US D895,739 S

1 1
1
1 1

at

11

Figure 4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 31 of 56

U.S. Patent Sep. 8, 2020 Sheet 5 of 8 US D895,739 S

1
1
1

1
1

Figure 5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 32 of 56

U.S. Patent Sep. 8 , 2020 Sheet 6 of 8 US D895,739

to ur

Figure 6
NA

H
?
H
H

Figure 7
?
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 33 of 56

U.S. Patent Sep. 8, 2020 Sheet 7 of 8 US D895,739 S

ud .

Figure 8
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 34 of 56

U.S. Patent Sep. 8, 2020 Sheet 8 of 8 US D895,739 S

TIN F
? DE

)
97 EES
?

Figure 9
Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 35 of 56

EXHIBIT A-4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 36 of 56

USOOD902329S

( 12 ) Jaquish
Unitedet alStates
.
Design Patent ((4510)) Date
PatentofNoPatent
.: : US D902,329 S
** *Nov. 17, 2020
( 54 ) EXERCISE APPARATUS 4,200,281 A 4/1980 Wang
4,257,592 A 3/1981 Jones
( 71 ) Applicant: Jaquish Biomedical Corporation , 4,441,707 A 4/1984 Bosch
5,178,596 A 1/1993 McIntire
Nevada City, CA (US ) 5,197,934 A 3/1993 Wirtz
D342,771 S 12/1993 Tandberg
( 72 ) Inventors : John Paul Jaquish , Nevada City, CA D353,419 S 12/1994 Sprague
(US ) ; Paul Edward Jaquish , Nevada 5,514,058 A 5/1996 Buoni
City, CA ( US ) 5,540,642 A 7/1996 Sprague
5,653,665 A 8/1997 Neeley
5,688,213 A 11/1997 Recker
( 73 ) Assignee : Jaquish Biomedical Corporation , (Continued )
Nevada City, CA (US )
This patent is subject to a terminal dis FOREIGN PATENT DOCUMENTS
( * ) Notice :
claimer . EP 2764896 A1 8/2014
KR 10200000 5/2000
( ** ) Term : 15 Years
Primary Examiner — George D. Kirschbaum
( 21 ) Appl. No .: 29 /734,057 (74 ) Attorney, Agent, or Firm — Morgan , Lewis &
Bockius LLP
(22 ) Filed : May 8, 2020
Related U.S. Application Data ( 57 ) CLAIM
( 63 ) Continuation of application No. 35 / 001,051 , filed on The ornamental design for an exercise apparatus, as shown
and described .
Jul. 17 , 2015 (U.S. filing date under 35 U.S.C. 384 ) ,
and having an international filing date of Jul . 17 , DESCRIPTION
2015 , which is a continuation of application No.
29/ 515,595 , filed on Jan. 23 , 2015 , now Pat . No. Des .
778,374 . FIG . 1 is a first perspective view of an exercise apparatus
( 51 ) LOC ( 12) Cl . 21-02 showing our new design ;
(52) U.S. CI. FIG . 2 is a second perspective view thereof;
USPC D21 /673 FIG . 3 is a front view of the design of FIG . 2 ;
FIG . 4 is a rear view of the design of FIG . 2 ;
( 58 ) Field of Classification Search FIG . 5 is a side view of the design of FIG . 2 , wherein the
USPC D21 / 662 , 673 , 679 opposite side of the exercise apparatus is a mirror image of
CPC A63B 23/0355 ; A63B 23/03525 ; A63B the side view ;
21/0552 , A63B 21/02 , A63B 21/0004 FIG . 6 is a top view of the design of FIG . 2 ;
See application file for complete search history . FIG . 7 is an enlarged view of FIG . 1 ; and,
( 56 ) References Cited FIG . 8 is a cross - sectional view taken along the lines 8-8 of
FIG . 7 .
U.S. PATENT DOCUMENTS The broken lines depict unclaimed environmental subject
matter.
1,019,861 A 3/1912 Titus
3,193,288 A 7/1965 Vell 1 Claim , 8 Drawing Sheets
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 37 of 56

US D902,329 S
Page 2

( 56 ) References Cited D657,008 S 4/2012

11/2012
Markovic
Guarrasi
D670,345 S
U.S. PATENT DOCUMENTS D682,374 S 5/2013 Wilkinson
8,870,722 B2 10/2014 Kassel
5,746,687 A * 5/1998 Vial A63B 21/0552 D723,637 S 3/2015 Mercado
482/125 D724,163 S 3/2015 Kelley
5,776,041 A 7/1998 Fisher 9,254,405 B1 * 2/2016 Marji A63B 21/02
5,885,196 A 3/1999 Gvoich A63B 21/0004 D764,607 S 8/2016 Beckford
482/122 2002/0137609 Al 9/2002 Rosati
6,203,476 B1 3/2001 Wang et al . 2005/0239617 A1 10/2005 Tenaglia
6,280,366 B1 8/2001 Hsieh 2007/0207903 A1 9/2007 Csabai
D474,818 S 5/2003 Yu 2007/0207905 Al 9/2007 Winston
D482,748 S 11/2003 Flynt 2010/0152002 A1 * 6/2010 Knight A63B 21/0552
7,052,449 B2 5/2006 Chen 482/93
D526,367 S 8/2006 Loccarini 2010/0173760 A1 * 7/2010 Hall A63B 23/03525
7,175,574 B2 2/2007 Carmel et al . 482/129
7,387,599 B1 6/2008 Hsu 2014/0038793 A1 * 2/2014 Hetzel A63B 23/0355
D590,457 S 4/2009 Mishan 482/122
7,578,775 B2 8/2009 Terry 2014/0228180 A1 8/2014 Walker
7,601,101 B2 10/2009 Jackson 2015/0367159 Al 12/2015 Harris
D604,374 S 11/2009 Bizzell
7,922,624 B1 4/2011 Fairhurst * cited by examiner
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 38 of 56

U.S. Patent Nov. 17 , 2020 Sheet 1 of 8 US D902,329 S

}
$

Figure 7

Figure 1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 39 of 56

U.S. Patent Nov. 17 , 2020 Sheet 2 of 8 US D902,329 S

1
1
1

1
1

Figure 2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 40 of 56

U.S. Patent Nov. 17 , 2020 Sheet 3 of 8 US D902,329 S

CD715

1
1
1

11

1
1
1
1

1 1
1

I
1

01
Figure 3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 41 of 56

U.S. Patent Nov. 17 , 2020 Sheet 4 of 8 US D902,329 S

Figure 4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 42 of 56

U.S. Patent Nov. 17 , 2020 Sheet 5 of 8 US D902,329 S

1
1

1
1

1 1

Figure 5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 43 of 56

U.S. Patent Nov. 17 , 2020 Sheet 6 of 8 US D902,329 S

Figure 6
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 44 of 56

U.S. Patent Nov. 17 , 2020 Sheet 7 of 8 US D902,329 S

8
1

8
A

Figure 7
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 45 of 56

U.S. Patent Nov. 17 , 2020 Sheet 8 of 8 US D902,329 S

are =

=
C
Figure 8
Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 46 of 56

EXHIBIT A-5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 47 of 56

USOOD8950328

( 12 ) Jaquish
Unitedet alStates
.
Design Patent ((4510)) Date
PatentofNoPatent
.: : US D895,032 S
*Sep. 1 , 2020
( 54 ) EXERCISE APPARATUS 4,200,281 A 4/1980 Wang
4,257,592 A 3/1981 Jones
( 71 ) Applicant: Jaquish Biomedical Corporation , 4,441,707 A 4/1984 Bosch
5,178,596 A 1/1993 McIntire
Nevada City, CA (US ) 5,197,934 A 3/1993 Wirtz
D342,771 S 12/1993 Tandberg
( 72 ) Inventors : John Paul Jaquish , Nevada City, CA D353,419 S 12/1994 Sprague
(US ) ; Paul Edward Jaquish , Nevada 5,514,058 A 5/1996 Buoni
City, CA ( US ) 5,540,642 A 7/1996 Sprague
5,653,665 A 8/1997 Neeley
5,688,213 A 11/1997 Recker
( 73 ) Assignee : Jaquish Biomedical Corporation , (Continued )
Nevada City, CA (US )
This patent is subject to a terminal dis FOREIGN PATENT DOCUMENTS
( * ) Notice :
claimer . EP 2764896 A1 8/2014
KR 10200000 5/2000
( ** ) Term : 15 Years
Primary Examiner — George D. Kirschbaum
( 21 ) Appl . No .: 29 /734,015 (74 ) Attorney, Agent, or Firm — Morgan , Lewis &
Bockius LLP
(22 ) Filed : May 8, 2020
Related U.S. Application Data ( 57 ) CLAIM
( 63 ) Continuation of application No. 35 / 001,051 , filed on The ornamental design for an exercise apparatus, as shown
and described .
Jul. 17 , 2015 (U.S. filing date under 35 U.S.C. 384 ) ,
and having an international filing date of Jul . 17 , DESCRIPTION
2015 , which is a continuation of application No.
29/ 515,595 , filed on Jan. 23 , 2015 , now Pat . No. Des .
778,374 . FIG . 1 is a first perspective view of an exercise apparatus
( 51 ) LOC ( 12) Cl . 21-02 showing our new design ;
(52) U.S. CI. FIG . 2 is a second perspective view thereof;
USPC D21 /673 FIG . 3 is a front view of the design of FIG . 2 ;
FIG . 4 is a rear view of the design of FIG . 2 ;
( 58 ) Field of Classification Search FIG . 5 is a side view of the design of FIG . 2 , wherein the
USPC D21 / 662 , 673 , 679 opposite side of the exercise apparatus is a mirror image of
CPC A63B 23/0355 ; A63B 23/03525 ; A63B the side view ;
21/0552 , A63B 21/02 , A63B 21/0004 FIG . 6 is a top view of the design of FIG . 2 ;
See application file for complete search history . FIG . 7 is a bottom view of the design of FIG . 2 ;
( 56 ) References Cited FIG . 8 is a first enlarged view of FIG . 1 ; and,
FIG . 9 is a second enlarged view of FIG . 1 .
U.S. PATENT DOCUMENTS The broken lines depict unclaimed environmental subject
matter.
1,019,861 A 3/1912 Titus
3,193,288 A 7/1965 Vell 1 Claim , 8 Drawing Sheets
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 48 of 56

US D895,032 S
Page 2

( 56 ) References Cited D657,008 S 4/2012

11/2012
Markovic
Guarrasi
D670,345 S
U.S. PATENT DOCUMENTS D682,374 S 5/2013 Wilkinson
8,870,722 B2 10/2014 Kassel
5,746,687 A * 5/1998 Vial A63B 21/0552 D723,637 S 3/2015 Mercado
482/125 D724,163 S 3/2015 Kelley
5,776,041 A 7/1998 Fisher 9,254,405 B1 * 2/2016 Marji A63B 21/02
5,885,196 A 3/1999 Gvoich A63B 21/0004 D764,607 S 8/2016 Beckford
482/122 2002/0137609 Al 9/2002 Rosati
6,203,476 B1 3/2001 Wang et al . 2005/0239617 A1 10/2005 Tenaglia
6,280,366 B1 8/2001 Hsieh 2007/0207903 A1 9/2007 Csabai
D474,818 S 5/2003 Yu 2007/0207905 Al 9/2007 Winston
D482,748 S 11/2003 Flynt 2010/0152002 A1 * 6/2010 Knight A63B 21/0552
7,052,449 B2 5/2006 Chen 482/93
D526,367 S 8/2006 Loccarini 2010/0173760 A1 * 7/2010 Hall A63B 23/03525
7,175,574 B2 2/2007 Carmel et al . 482/129
7,387,599 B1 6/2008 Hsu 2014/0038793 A1 * 2/2014 Hetzel A63B 23/0355
D590,457 S 4/2009 Mishan 482/122
7,578,775 B2 8/2009 Terry 2014/0228180 A1 8/2014 Walker
7,601,101 B2 10/2009 Jackson 2015/0367159 Al 12/2015 Harris
D604,374 S 11/2009 Bizzell
7,922,624 B1 4/2011 Fairhurst * cited by examiner
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 49 of 56

U.S. Patent Sep. 1 , 2020 Sheet 1 of 8 US D895,032 S

1 $
1

1
1
H
1

Figure 8
1 1

IM
Figure 9

Figure 1
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 50 of 56

U.S. Patent Sep. 1 , 2020 Sheet 2 of 8 US D895,032 S

1
1

Figure 2
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 51 of 56

U.S. Patent Sep. 1 , 2020 Sheet 3 of 8 US D895,032 S

1
}
I

11

)
1
1
1

Figure 3
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 52 of 56

U.S. Patent Sep. 1 , 2020 Sheet 4 of 8 US D895,032 S

1
1
1 1

!
1

1
1
1

Figure 4
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 53 of 56

U.S. Patent Sep. 1 , 2020 Sheet 5 of 8 US D895,032 S

I
1

Figure 5
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 54 of 56

U.S. Patent Sep. 1 , 2020 Sheet 6 of 8 US D895,032 S

AV
RU

Figure 6

11

Hi ** H

Figure 7
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 55 of 56

U.S. Patent Sep.1, 2020 Sheet 7 of 8 US D895,032 S

*
*
:

Figure 8
 Case 6:21-cv-00052 Document 1-1 Filed 01/19/21 Page 56 of 56

U.S. Patent Sep. 1 , 2020 Sheet 8 of 8 US D895,032 S

III
11
11u
TIS
H
C
?7
45
?.

Figure 9
JS 44 (Rev. 10/20) CIVIL
Case 6:21-cv-00052 COVER
Document 1-2 SHEET
Filed 01/19/21 Page 1 of 2
The JS 44 civil cover sheet and the information contained herein neither replace nor supplement the filing and service of pleadings or other papers as required by law, except as
provided by local rules of court. This form, approved by the Judicial Conference of the United States in September 1974, is required for the use of the Clerk of Court for the
purpose of initiating the civil docket sheet. (SEE INSTRUCTIONS ON NEXT PAGE OF THIS FORM.)
I. (a) PLAINTIFFS DEFENDANTS
Jaquish Biomedical Corp. GYP Technology (HONGKONG) Co. Ltd. d/b/a Tikaton

(b) County of Residence of First Listed Plaintiff County of Residence of First Listed Defendant
(EXCEPT IN U.S. PLAINTIFF CASES) (IN U.S. PLAINTIFF CASES ONLY)
NOTE: IN LAND CONDEMNATION CASES, USE THE LOCATION OF
THE TRACT OF LAND INVOLVED.

(c) Attorneys (Firm Name, Address, and Telephone Number) Attorneys (If Known)

II. BASIS OF JURISDICTION (Place an “X” in One Box Only) III. CITIZENSHIP OF PRINCIPAL PARTIES (Place an “X” in One Box for Plaintiff
(For Diversity Cases Only) and One Box for Defendant)
1 U.S. Government ✖ 3 Federal Question PTF DEF PTF DEF
Plaintiff (U.S. Government Not a Party) Citizen of This State 1 1 Incorporated or Principal Place 4 4
of Business In This State

2 U.S. Government 4 Diversity Citizen of Another State 2 2 Incorporated and Principal Place ✖ 5 x 5
Defendant (Indicate Citizenship of Parties in Item III) of Business In Another State

Citizen or Subject of a 3 3 Foreign Nation 6 6

Foreign Country
IV. NATURE OF SUIT (Place an “X” in One Box Only) Click here for: Nature of Suit Code Descriptions.
CONTRACT TORTS FORFEITURE/PENALTY BANKRUPTCY OTHER STATUTES
110 Insurance PERSONAL INJURY PERSONAL INJURY 625 Drug Related Seizure 422 Appeal 28 USC 158 375 False Claims Act
120 Marine 310 Airplane 365 Personal Injury - of Property 21 USC 881 423 Withdrawal 376 Qui Tam (31 USC
130 Miller Act 315 Airplane Product Product Liability 690 Other 28 USC 157 3729(a))
140 Negotiable Instrument Liability 367 Health Care/ 400 State Reapportionment
150 Recovery of Overpayment 320 Assault, Libel & Pharmaceutical PROPERTY RIGHTS 410 Antitrust
& Enforcement of Judgment Slander Personal Injury 820 Copyrights 430 Banks and Banking
151 Medicare Act 330 Federal Employers’ Product Liability ✖ 830 Patent 450 Commerce
152 Recovery of Defaulted Liability 368 Asbestos Personal 835 Patent - Abbreviated 460 Deportation
Student Loans 340 Marine Injury Product New Drug Application 470 Racketeer Influenced and
(Excludes Veterans) 345 Marine Product Liability 840 Trademark Corrupt Organizations
153 Recovery of Overpayment Liability PERSONAL PROPERTY LABOR 880 Defend Trade Secrets 480 Consumer Credit
of Veteran’s Benefits 350 Motor Vehicle 370 Other Fraud 710 Fair Labor Standards Act of 2016 (15 USC 1681 or 1692)
160 Stockholders’ Suits 355 Motor Vehicle 371 Truth in Lending Act 485 Telephone Consumer
190 Other Contract Product Liability 380 Other Personal 720 Labor/Management SOCIAL SECURITY Protection Act
195 Contract Product Liability 360 Other Personal Property Damage Relations 861 HIA (1395ff) 490 Cable/Sat TV
196 Franchise Injury 385 Property Damage 740 Railway Labor Act 862 Black Lung (923) 850 Securities/Commodities/
362 Personal Injury - Product Liability 751 Family and Medical 863 DIWC/DIWW (405(g)) Exchange
Medical Malpractice Leave Act 864 SSID Title XVI 890 Other Statutory Actions
REAL PROPERTY CIVIL RIGHTS PRISONER PETITIONS 790 Other Labor Litigation 865 RSI (405(g)) 891 Agricultural Acts
210 Land Condemnation 440 Other Civil Rights Habeas Corpus: 791 Employee Retirement 893 Environmental Matters
220 Foreclosure 441 Voting 463 Alien Detainee Income Security Act FEDERAL TAX SUITS 895 Freedom of Information
230 Rent Lease & Ejectment 442 Employment 510 Motions to Vacate 870 Taxes (U.S. Plaintiff Act
240 Torts to Land 443 Housing/ Sentence or Defendant) 896 Arbitration
245 Tort Product Liability Accommodations 530 General 871 IRS—Third Party 899 Administrative Procedure
290 All Other Real Property 445 Amer. w/Disabilities - 535 Death Penalty IMMIGRATION 26 USC 7609 Act/Review or Appeal of
Employment Other: 462 Naturalization Application Agency Decision
446 Amer. w/Disabilities - 540 Mandamus & Other 465 Other Immigration 950 Constitutionality of
Other 550 Civil Rights Actions State Statutes
448 Education 555 Prison Condition
560 Civil Detainee -
Conditions of
Confinement
V. ORIGIN (Place an “X” in One Box Only)
1 Original 2 Removed from 3 Remanded from 4 Reinstated or 5 Transferred from 6 Multidistrict 8 Multidistrict
Proceeding State Court Appellate Court Reopened Another District Litigation - Litigation -
(specify) Transfer Direct File
Cite the U.S. Civil Statute under which you are filing (Do not cite jurisdictional statutes unless diversity):
35 U.S.C. § 1 et seq., including, but not limited to, 35 U.S.C. §§ 271 and 281
VI. CAUSE OF ACTION Brief description of cause:
Patent Infringement
VII. REQUESTED IN CHECK IF THIS IS A CLASS ACTION DEMAND $ CHECK YES only if demanded in complaint:
COMPLAINT: UNDER RULE 23, F.R.Cv.P. JURY DEMAND: ✖ Yes No
VIII. RELATED CASE(S)
(See instructions):
IF ANY JUDGE DOCKET NUMBER
DATE SIGNATURE OF ATTORNEY OF RECORD
01/19/2021 /s/ Elizabeth M. Chiaviello
FOR OFFICE USE ONLY

RECEIPT # AMOUNT APPLYING IFP JUDGE MAG. JUDGE

JS 44 Reverse (Rev. 10/20) Case 6:21-cv-00052 Document 1-2 Filed 01/19/21 Page 2 of 2
INSTRUCTIONS FOR ATTORNEYS COMPLETING CIVIL COVER SHEET FORM JS 44
Authority For Civil Cover Sheet

The JS 44 civil cover sheet and the information contained herein neither replaces nor supplements the filings and service of pleading or other papers as
required by law, except as provided by local rules of court. This form, approved by the Judicial Conference of the United States in September 1974, is
required for the use of the Clerk of Court for the purpose of initiating the civil docket sheet. Consequently, a civil cover sheet is submitted to the Clerk of
Court for each civil complaint filed. The attorney filing a case should complete the form as follows:

I.(a) Plaintiffs-Defendants. Enter names (last, first, middle initial) of plaintiff and defendant. If the plaintiff or defendant is a government agency, use
only the full name or standard abbreviations. If the plaintiff or defendant is an official within a government agency, identify first the agency and then
the official, giving both name and title.
(b) County of Residence. For each civil case filed, except U.S. plaintiff cases, enter the name of the county where the first listed plaintiff resides at the
time of filing. In U.S. plaintiff cases, enter the name of the county in which the first listed defendant resides at the time of filing. (NOTE: In land
condemnation cases, the county of residence of the "defendant" is the location of the tract of land involved.)
(c) Attorneys. Enter the firm name, address, telephone number, and attorney of record. If there are several attorneys, list them on an attachment, noting
in this section "(see attachment)".

II. Jurisdiction. The basis of jurisdiction is set forth under Rule 8(a), F.R.Cv.P., which requires that jurisdictions be shown in pleadings. Place an "X"
in one of the boxes. If there is more than one basis of jurisdiction, precedence is given in the order shown below.
United States plaintiff. (1) Jurisdiction based on 28 U.S.C. 1345 and 1348. Suits by agencies and officers of the United States are included here.
United States defendant. (2) When the plaintiff is suing the United States, its officers or agencies, place an "X" in this box.
Federal question. (3) This refers to suits under 28 U.S.C. 1331, where jurisdiction arises under the Constitution of the United States, an amendment
to the Constitution, an act of Congress or a treaty of the United States. In cases where the U.S. is a party, the U.S. plaintiff or defendant code takes
precedence, and box 1 or 2 should be marked.
Diversity of citizenship. (4) This refers to suits under 28 U.S.C. 1332, where parties are citizens of different states. When Box 4 is checked, the
citizenship of the different parties must be checked. (See Section III below; NOTE: federal question actions take precedence over diversity
cases.)

III. Residence (citizenship) of Principal Parties. This section of the JS 44 is to be completed if diversity of citizenship was indicated above. Mark this
section for each principal party.

IV. Nature of Suit. Place an "X" in the appropriate box. If there are multiple nature of suit codes associated with the case, pick the nature of suit code
that is most applicable. Click here for: Nature of Suit Code Descriptions.

V. Origin. Place an "X" in one of the seven boxes.

Original Proceedings. (1) Cases which originate in the United States district courts.
Removed from State Court. (2) Proceedings initiated in state courts may be removed to the district courts under Title 28 U.S.C., Section 1441.
Remanded from Appellate Court. (3) Check this box for cases remanded to the district court for further action. Use the date of remand as the filing
date.
Reinstated or Reopened. (4) Check this box for cases reinstated or reopened in the district court. Use the reopening date as the filing date.
Transferred from Another District. (5) For cases transferred under Title 28 U.S.C. Section 1404(a). Do not use this for within district transfers or
multidistrict litigation transfers.
Multidistrict Litigation – Transfer. (6) Check this box when a multidistrict case is transferred into the district under authority of Title 28 U.S.C.
Section 1407.
Multidistrict Litigation – Direct File. (8) Check this box when a multidistrict case is filed in the same district as the Master MDL docket.
PLEASE NOTE THAT THERE IS NOT AN ORIGIN CODE 7. Origin Code 7 was used for historical records and is no longer relevant due to
changes in statue.

VI. Cause of Action. Report the civil statute directly related to the cause of action and give a brief description of the cause. Do not cite jurisdictional
statutes unless diversity. Example: U.S. Civil Statute: 47 USC 553 Brief Description: Unauthorized reception of cable service.

VII. Requested in Complaint. Class Action. Place an "X" in this box if you are filing a class action under Rule 23, F.R.Cv.P.
Demand. In this space enter the actual dollar amount being demanded or indicate other demand, such as a preliminary injunction.
Jury Demand. Check the appropriate box to indicate whether or not a jury is being demanded.

VIII. Related Cases. This section of the JS 44 is used to reference related pending cases, if any. If there are related pending cases, insert the docket
numbers and the corresponding judge names for such cases.

Date and Attorney Signature. Date and sign the civil cover sheet.